Single Dose Tolerability and Pharmacokinetics of IBI112 in Healthy Subjects
Clinical trial NCT04511624 · COMPLETED
Trial details
- NCT number
- NCT04511624
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-27
- Primary completion
- 2022-07-22
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.